Next Article in Journal
The Prevalence of TET2 Gene Mutations in Patients with BCR-ABL-Negative Myeloproliferative Neoplasms (MPN): A Systematic Review and Meta-Analysis
Next Article in Special Issue
The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?
Previous Article in Journal
Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma
Previous Article in Special Issue
Evolving Treatment of Advanced Hepatocellular Carcinoma in the Asia–Pacific Region: A Review and Multidisciplinary Expert Opinion
 
 
Review

Article Versions Notes

Cancers 2021, 13(12), 3076; https://doi.org/10.3390/cancers13123076
Action Date Notes Link
article xml file uploaded 20 June 2021 14:17 CEST Original file -
article xml uploaded. 20 June 2021 14:17 CEST Update https://www.mdpi.com/2072-6694/13/12/3076/xml
article pdf uploaded. 20 June 2021 14:17 CEST Version of Record https://www.mdpi.com/2072-6694/13/12/3076/pdf
article html file updated 20 June 2021 14:18 CEST Original file -
article html file updated 27 July 2022 01:07 CEST Update https://www.mdpi.com/2072-6694/13/12/3076/html
Back to TopTop